锥切病理特征对早期宫颈癌根治性子宫切除标本中中危及高危特征的预测价值
回顾性分析1995至2016年115例早期宫颈癌患者的临床病理资料,评估锥切标本病理特征对根治性子宫切除标本中中危和高危特征的预测价值。锥切与子宫切除标本的叠加病理未显著影响风险分层,仅影响4.3%的患者;但锥切标本存在淋巴血管间隙浸润(LVSI)时,51.2%的患者达到中危/高危标准,而无LVSI者仅9.5%。
要点
- 锥切与子宫切除标本叠加病理未显著影响风险分层,仅影响4.3%的患者。
- 锥切标本存在LVSI时,51.2%的患者达到中危/高危标准,而无LVSI者仅9.5%。
- 锥切标本LVSI阳性者中,60%符合中危标准,37%符合高危标准。
核心结论
- 在早期宫颈癌女性中,锥切与子宫切除标本的叠加病理未显著影响风险分层,仅影响4.3%的患者。
- 锥切标本存在LVSI与中危标准相关(60%的病例)及高危标准相关(37%的病例)。
- 由于符合中危/高危标准的患者满足辅助治疗推荐,锥切标本中LVSI的评估可能影响宫颈癌女性初始治疗的选择。
研究设计与样本
- 回顾性识别1995年至2016年接受锥切后行根治性子宫切除的早期宫颈癌患者。
- 从患者医疗记录中提取临床和病理数据。
- 共识别115例患者。
主要发现
- 基于最终病理,70.5%为低危,10.4%为中危,19.1%为高危。
- 锥切标本的叠加病理特征将使5例患者从低危重新分类为中危组。
- 浸润深度与最终病理结果不相关。
- 锥切标本存在LVSI时,51.2%的患者达到中危/高危标准;而无LVSI者仅9.5%。
- 锥切标本存在LVSI时,60%的病例符合中危标准,37%的病例符合高危标准。
临床怎么用
- 作者认为,锥切标本中LVSI的评估可能影响宫颈癌女性初始治疗的选择。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The impact of pathologic features of a cone biopsy on the management of women with early stage cervical cancer is understudied. Our objective was to evaluate the additive value of pathologic features of a cone biopsy toward identifying patients with high risk tumors for which adjuvant therapy may be indicated. METHODS: Patients with early stage cervical cancer undergoing a conization followed by radical hysterectomy from 1995 to 2016 were retrospectively identified. Clinical and pathologic data were abstracted from patient medical records. RESULTS: A total of 115 patients were identified. Based on final pathology, 70.5% were low risk, 10.4% intermediate risk, and 19.1% were high risk. The additive pathologic features of the conization specimen would have reclassified five patients from low into the intermediate risk group. Though depth of invasion did not correlate with final pathology results, when lymphovascular space invasion (LVSI) was present in the conization specimen, 51.2% of patients were noted to meet intermediate/high risk; compared to only 9.5% without LVSI. CONCLUSIONS: In women with early stage cervical cancer, additive pathology of the conization and hysterectomy specimen did not significantly impact risk stratification, only affecting 4.3% of patients. However, presence of LVSI in the conization was associated with intermediate risk criteria in 60% of cases and high risk criteria in 37% of cases. As patients with intermediate/high risk criteria would meet recommendations for adjuvant therapy, the evaluation of LVSI in conization specimens may influence the selection of primary treatment for women with cervical cancer.
引用
- Hutchcraft ML, Smith B, McLaughlin EM, et al. Conization pathologic features as a predictor of intermediate and high risk features on radical hysterectomy specimens in early stage cervical cancer. Gynecol Oncol. 2019. PMID: 30718123. doi:10.1016/j.ygyno.2019.01.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。